Ola B. Dale

Trondheim, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 193 publications

Ethanol pharmacokinetics before and after sleeve gastrectomy and Roux-en-Y gastric bypass: a 3 year prospective study (the BAR-TRIAL).

Ethanol pharmacokinetics before and after sleeve gastrectomy and Roux-en-Y gastric bypass: a 3 year prospective study (the BAR-TRIAL).

Journal: International journal of obesity (2005)

Published: July 15, 2025

Nitazenes: review of comparative pharmacology and antagonist action.

Nitazenes: review of comparative pharmacology and antagonist action.

Journal: Clinical toxicology (Philadelphia, Pa.)

Published: May 27, 2025

Pharmacokinetics of subcutaneous and intravenous bolus doses of morphine in palliative care cancer patients receiving infusion of morphine: A pharmacokinetic substudy of a randomized controlled trial.

Pharmacokinetics of subcutaneous and intravenous bolus doses of morphine in palliative care cancer patients receiving infusion of morphine: A pharmacokinetic substudy of a randomized controlled trial.

Journal: British journal of clinical pharmacology

Published: November 28, 2024

We need real-time monitoring of overdoses

We need real-time monitoring of overdoses

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Published: June 27, 2024

Heightened mortality risk after a non-fatal opioid overdose: Risk factors for mortality in the week following emergency treatment.

Heightened mortality risk after a non-fatal opioid overdose: Risk factors for mortality in the week following emergency treatment.

Journal: Addiction (Abingdon, England)

Published: February 15, 2024

Clinical Pharmacokinetics and Pharmacodynamics of Naloxone.

Clinical Pharmacokinetics and Pharmacodynamics of Naloxone.

Journal: Clinical pharmacokinetics

Published: February 07, 2024

Pharmacokinetic and neuroimmune pharmacogenetic impacts on slow-release morphine cancer pain control and adverse effects.

Pharmacokinetic and neuroimmune pharmacogenetic impacts on slow-release morphine cancer pain control and adverse effects.

Journal: The pharmacogenomics journal

Published: December 08, 2023

Naloxone administration-no balance without titration.

Naloxone administration-no balance without titration.

Journal: Addiction (Abingdon, England)

Published: May 04, 2022

Pharmacokinetic considerations for community-based dosing of nasal naloxone in opioid overdose in adults.

Pharmacokinetic considerations for community-based dosing of nasal naloxone in opioid overdose in adults.

Journal: Expert opinion on drug metabolism & toxicology

Published: May 02, 2022

Intranasal Naloxone Administration.

Intranasal Naloxone Administration.

Journal: The New England journal of medicine

Published: June 16, 2021

Comparison of intranasal and intramuscular naloxone in opioid overdoses managed by ambulance staff: a double-dummy, randomised, controlled trial.

Comparison of intranasal and intramuscular naloxone in opioid overdoses managed by ambulance staff: a double-dummy, randomised, controlled trial.

Journal: Addiction (Abingdon, England)

Published: May 19, 2021

A Clinical Description of Chronic Pain in a General Population Using ICD-10 and ICD-11 (The HUNT Pain Examination Study).

A Clinical Description of Chronic Pain in a General Population Using ICD-10 and ICD-11 (The HUNT Pain Examination Study).

Journal: The journal of pain

Published: March 03, 2021

Showing 1-12 of 193

Last Updated: 09/26/2026